academy.hematology.org/mod/quiz/attempt.php?attempt=29566&cmid=27154&page=20
1 Users
0 Comments
4 Highlights
0 Notes
Tags
Top Highlights
chronic myelogenous leukemia (CML) comes for routine evaluation
79%
3.7
patient’s resistance to imatinib?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.